Cinnamycin

Cinnamycin

$280.00 - 1 mg

$980.00 - 5 mg

All prices in Australian dollars

Code
BIA-C1432
Synonyms
Lanthiopeptin, Ro 09-0198
CAS #
110655-58-8
Molecular Formula
C89H125N25O25S3
Molecular Weight
2041.3
Purity
>95% by HPLC
Long Term Storage
-20°C
Solubility
Soluble in ethanol, methanol, DMF or DMSO. Poor water solubility.

Download Data Sheets

Application Notes

Cinnamycin (lanthiopeptin) is a high molecular weight tricyclic antibiotic produced by several species of Streptoverticillium. Cinnamycin is a potent indirect inhibitor of phospholipase A2, acting by specifically sequestering phosphatidylethanolamine (PE), a major component of the mammalian plasma cell membrane. Cinnamycin induces trans-bilayer phospholipid movement in cell membranes to expose internally bound PE. At high surface concentrations of PE, cinnamycin induces membrane reorganisation including membrane fusion and alteration of gross morphology.

References

  • Lanthiopeptin, a new peptide antibiotic. Production, isolation and properties of lanthiopeptin. Naruse N. J. Antibiot. 1989, 42, 837.
  • Duramycins B and C, two new lanthionine containing antibiotics as inhibitors of phospholipase A2. Structural revision of duramycin and cinnamycin. Fredenhagen A. et al., J. Antibiot. 1990, 43, 1403.
  • Mode of action of the lanthionine-containing peptide antibiotics duramycin, duramycin B and C, and cinnamycin as indirect inhibitors of phospholipase A2. Märki F. et al., Biochem. Pharmacol. 1991, 42, 2027.

Other Products